Filing Flows › Longevity Health Holdings (XAGE) › Q1 2026 › vs Q1 2025
Longevity Health Holdings (XAGE) Q1 2026 vs Q1 2025 (year over year)
Longevity Health Holdings's revenue fell $119K (-23%) from $510K in Q1 2025 to $392K in Q1 2026.
Longevity Health Holdings, Q1 2026: revenue $392K (-23% year over year), operating margin -339.1%, net loss $1.4M, operating cash flow −$485K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $392K | $510K | −$119K | -23% |
| Net loss | $1.4M | $1.5M | −$74K | -5% |
| Costs & expenses | $1.8M | $2.0M | −$194K | -10% |
| Operating costs | $1.7M | $2.0M | −$297K | -15% |
| Interest & other, net | $103K | −$1K | $104K | — |
| Cost of revenue | $155K | $241K | −$86K | -36% |
| Research & development | $55K | $197K | −$141K | -72% |
| Sales & marketing | $271K | $281K | −$10K | -4% |
| Other operating costs | $1.2M | $1.3M | −$60K | -5% |
| Operating cash sources | $1.4M | $1.5M | −$74K | -5% |
| Depreciation & amortization | $15K | $24K | −$9K | -37% |
| Share-based compensation | $146K | $115K | $31K | +27% |
| Working capital & other | $785K | $614K | $171K | +28% |
| Cash used in operations | $485K | $753K | −$268K | -36% |
| Net loss absorbed | $1.4M | $1.5M | −$74K | -5% |
Questions
How much did Longevity Health Holdings's revenue grow year over year in Q1 2026?
Longevity Health Holdings's revenue fell $119K (-23%) from $510K in Q1 2025 to $392K in Q1 2026.